Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Archive of Views

<< 2011 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2013 >>

1 November 2012: People, Not Technology are the Heart of London's Tech City

By Stephen Caddick, Vice-Provost (Enterprise) at UCL
It's a rare thing to hear a resounding success story for UK Plc nowadays. Yet Tech City, the Government's anointed digital and media hub in East London, is just that.
More...

<< 2011 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2013 >>